
MC1R-selective melanocortin receptor agonist
Melanotan I
MC1R-selective melanocortin receptor agonist. Supplied for laboratory research use only.
- Same molecule as FDA-approved Scenesse (afamelanotide)
- Approval is one rare condition (EPP), not tanning
- Phase 3: 69.4 hrs pain-free sun exposure vs. 40.8 placebo
- Supplied for laboratory research use only. Not for human or veterinary use.
90-Day Money-Back Guarantee
Every order is covered for ninety days from delivery. If you decide against it inside that window, contact us and we will refund the purchase price.
Research use only. Not for human or veterinary use or consumption. This product is not approved by the FDA and is not intended to diagnose, treat, cure or prevent any disease.
What it is
Development status
Melanotan I is the same molecule as afamelanotide, approved by the FDA as Scenesse on 8 October 2019 for increasing pain-free light exposure in adults with erythropoietic protoporphyria, a rare disorder. That is the only approved use. This product is not that medicine and is supplied for laboratory research use only.
Development status is stated above. No efficacy claim is made on this page.
Shipping & returns
The specifics
The details, if you want them.
Development
Where it is up to.
Peer-reviewed and the basis for FDA approval, for one narrow rare-disease indication. Not approved for tanning or cosmetic use.
Questions
The questions people actually ask.
What is Melanotan I?
Is this the same as Scenesse?
What does "Research Use Only" mean?
How is this vial supplied?
What is your refund policy?